0001209191-22-003532.txt : 20220118
0001209191-22-003532.hdr.sgml : 20220118
20220118171522
ACCESSION NUMBER: 0001209191-22-003532
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220114
FILED AS OF DATE: 20220118
DATE AS OF CHANGE: 20220118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Long Alison S
CENTRAL INDEX KEY: 0001891712
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38822
FILM NUMBER: 22535948
MAIL ADDRESS:
STREET 1: KALEIDO BIOSCIENCES, INC.
STREET 2: 65 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kaleido Biosciences, Inc.
CENTRAL INDEX KEY: 0001751299
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: 617-674-9000
MAIL ADDRESS:
STREET 1: 18 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-14
0
0001751299
Kaleido Biosciences, Inc.
KLDO
0001891712
Long Alison S
65 HAYDEN AVENUE
LEXINGTON
MA
02421
0
1
0
0
Chief Medical Officer
Restricted Stock Units
2022-01-14
4
A
0
46800
0.00
A
Common Stock
46800
46800
D
Restricted Stock Units
2022-01-14
4
A
0
125000
0.00
A
Common Stock
125000
125000
D
Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
The restricted stock units shall vest 100% on April 30, 2022 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer.
The restricted stock units shall vest on the earlier of 50% on January 14, 2023 and 50% on January 14, 2024 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer.
/s/ Alison S. Long
2022-01-18